ENGERIX-B

10MCG INJ SUS 25X0,5ML

SÚKL code 0057570
Name of the product ENGERIX-B 10 MCG
_MA_MEDICATION_DETAIL_INFO_MED_NAME i ENGERIX-B
Supplement 10MCG INJ SUS 25X0,5ML
Strenght 10MCG
Pharmaceutical form Suspension for injection
Package 25X0,5ML
Route Intramuscular use
Language of the pack Czech
Wrap type Vial
Legal status na lékařský předpis
Active substance HEPATITIS B SURFACE ANTIGEN (TEGIMINIS HEPATITIDIS B ANTIGENUM)
ATC group J07BC01
ATC group name HEPATITIDA B, PURIFIKOVANÝ ANTIGEN

Marketing authorisation information

Registration Number 59/ 170/87-A/C
Type of MA National
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 04. 2017
MA Holder GlaxoSmithKline Biologicals S.A., Rixensart
MA Holder country BELGIE
Actual MA holder GlaxoSmithKline Biologicals S.A., Rixensart
Actual MA holder country BELGIE

Back to list